Thyroid Gland Disorders Treatment
Thyroid Gland Disorders Treatment Market Forecasts to 2030 - Global Analysis By Type of Disorder (Hypothyroidism , Hyperthyroidism, Goiter, Thyroid Cancer, Hashimoto's Thyroiditis, Graves' Disease, Thyroid Nodules and Other Type of Disorders), Treatment Type, Route of Administration, Drug Type, Distribution Channel and By Geography
According to Stratistics MRC, the Global Thyroid Gland Disorders Treatment Market is accounted for $2.50 billion in 2024 and is expected to reach $3.69 billion by 2030 growing at a CAGR of 6.7% during the forecast period. Thyroid gland disorders treatment refers to medical interventions aimed at managing conditions that affect the thyroid, a small gland in the neck responsible for regulating metabolism. Common thyroid disorders include hypothyroidism (underactive thyroid), hyperthyroidism (overactive thyroid), thyroid nodules, and thyroid cancer. Treatment options vary based on the disorder and may include hormone replacement therapy, anti-thyroid medications, radioactive iodine, or surgery.
According to the Canadian Cancer Society 2022 report, close to 6,700 Canadians were diagnosed with thyroid cancer in the year 2022.
Market Dynamics:
Driver:
Rising incidence of thyroid disorders
The rising incidence of thyroid disorders and increasing awareness of thyroid health, coupled with advancements in diagnostic technologies, leads to earlier detection and treatment. This growing patient population drives demand for effective therapies, including medications, radioactive iodine therapy, and surgical interventions. Additionally, the prevalence of risk factors such as obesity and autoimmune diseases further escalates the market's growth. Consequently, pharmaceutical companies are increasingly investing in research and development to offer innovative treatment options.
Restraint:
High cost of treatments
The high cost of treatments for thyroid gland disorders significantly hinders market growth by limiting patient access to necessary therapies. Many individuals may forgo or delay treatment due to financial constraints, leading to worsening health conditions. Additionally, insurance coverage can be inadequate, further exacerbating affordability issues. This situation discourages pharmaceutical companies from investing in new therapies, reducing innovation and competition in the market. Consequently, the overall treatment landscape becomes less effective, impacting patient outcomes and increasing the burden on healthcare systems, thus hindering the growth of the market.
Opportunity:
Partnerships and collaborations
Partnerships and collaborations in the thyroid gland disorders treatment market enhance research and development, facilitating the sharing of expertise and resources among pharmaceutical companies, healthcare providers, and research institutions. These alliances foster innovation in drug development and the introduction of advanced treatment modalities, improving patient outcomes. Collaborative efforts can also lead to more effective marketing strategies, increasing awareness and accessibility of therapies. Furthermore, partnerships can accelerate clinical trials, shorten time-to-market for new treatments, and help in obtaining regulatory approvals, ultimately propelling market growth.
Threat:
Intense competition
Intense competition in the thyroid gland disorders treatment market can hinder growth by driving down prices, which may reduce profit margins for manufacturers. Companies may invest heavily in marketing and promotions to gain market share, leading to increased operational costs. Additionally, the focus on competitive differentiation can divert resources from research and development, stalling innovation in treatment options. As companies prioritize short-term gains over long-term advancements, patients may face limited access to cutting-edge therapies, ultimately impacting overall market growth and patient outcomes.
Covid-19 Impact
The COVID-19 pandemic impacted thyroid gland disorders treatment by disrupting healthcare services, delaying diagnoses, and limiting access to routine care. Patients with thyroid disorders, especially those requiring regular monitoring or surgery, face postponements due to overwhelmed healthcare systems. Telemedicine emerged as a solution, enabling remote consultations and management. Additionally, COVID-19's effects on the immune system and its association with thyroid inflammation (thyroiditis) increased concerns about potential virus-induced thyroid dysfunction, influencing treatment approaches during and after the pandemic.
The medications segment is expected to be the largest during the forecast period
During the forecast period, the medications segment is anticipated to register the largest market share, due to non-invasive solutions for managing common thyroid conditions. For hypothyroidism, levothyroxine is widely prescribed to replace deficient hormones, while antithyroid drugs like methimazole and propylthiouracil treat hyperthyroidism by reducing excessive hormone production. These medications provide long-term disease management, often delaying or preventing the need for surgery or radioactive iodine therapy.
The injectable segment is expected to have the highest CAGR during the forecast period
During the projection period, the injectable segment is expected to grow at the highest CAGR, due to efficient and targeted treatment options, especially for patients with severe thyroid dysfunction. Injectable treatments, such as thyroid hormone injections or biologics, provide rapid relief in conditions like hypothyroidism or thyroid-related emergencies. Their effectiveness in delivering precise doses ensures better control of thyroid hormone levels compared to oral medications. The growing adoption of injectables, advancements in drug formulations, and the increasing prevalence of thyroid disorders contribute to the segment's growth.
Region with largest share:
During the estimation period, the Asia Pacific region is expected to capture the largest market share due to raised awareness of thyroid diseases and advancements in medical technology. Key therapies include hormone replacement treatments, antithyroid medications, and surgical interventions. Countries like India and China are witnessing significant growth driven by a growing patient population and enhanced healthcare infrastructure. Moreover, government initiatives promoting thyroid health and the rising adoption of telemedicine are further propelling market growth.
Region with highest CAGR:
The North America region is projected to achieve the highest CAGR during the forecast period, due to the rising prevalence of thyroid-related conditions, including hypothyroidism and hyperthyroidism. Advances in diagnostic technologies and the increasing adoption of targeted therapies contribute to market expansion. Additionally, the growing awareness of thyroid disorders among healthcare professionals and patients drives demand for effective treatments, including hormone replacement therapies and surgical options. Moreover, the presence of key market players and ongoing research into innovative therapies are expected to further enhance market dynamics in the region.
Key players in the market
Some of the key players profiled in the Thyroid Gland Disorders Treatment Market include Abbott Laboratories, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Boehringer Ingelheim GmbH, Amgen Inc., Takeda Pharmaceutical Company Limited, ThyroSafe, LLC, Hormone Health Network, Zydus Cadila, Mylan N.V., Hikma Pharmaceuticals PLC, Endo International PLC, Genzyme Corporation and Roche Holding AG.
Key Developments:
In September 2024, Abbott announced collaboration with the DoD to develop and distribute a rapid COVID-19 test that provides results in under 30 minutes, aiming to enhance testing capabilities for military personnel.
In August 2024, Abbott acquired Walk Vascular, a company specializing in advanced vascular access solutions, enhancing its product portfolio in medical devices for vascular access.
In April 2024, Abbott formed a joint venture with Axiom Health to create digital health solutions that integrate diagnostics with data analytics to improve patient outcomes in chronic disease management.
Type of Disorders Covered:
• Hypothyroidism
• Hyperthyroidism
• Goiter
• Thyroid Cancer
• Hashimoto's Thyroiditis
• Graves' Disease
• Thyroid Nodules
• Other Type of Disorders
Treatment Types Covered:
• Medications
• Surgery
• Radiofrequency Ablation
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Injectable
• Topical
• Other Route of Administrations
Drug Types Covered:
• Levothyroxine
• Liothyronine
• Propylthiouracil
• Imidazole-Based Compounds
• Other Drug Types
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Clinics
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Thyroid Gland Disorders Treatment Market, By Type of Disorder
5.1 Introduction
5.2 Hypothyroidism
5.3 Hyperthyroidism
5.4 Goiter
5.5 Thyroid Cancer
5.6 Hashimoto's Thyroiditis
5.7 Graves' Disease
5.8 Thyroid Nodules
5.9 Other Type of Disorders
6 Global Thyroid Gland Disorders Treatment Market, By Treatment Type
6.1 Introduction
6.2 Medications
6.2.1 Hormone Replacement Therapy
6.2.2 Antithyroid Drugs
6.2.3 Radioactive Iodine Therapy
6.3 Surgery
6.3.1 Thyroidectomy
6.3.2 Lobectomy
6.4 Radiofrequency Ablation
6.5 Other Treatment Types
6.5.1 Nutritional Supplements
6.5.2 Herbal Remedies
7 Global Thyroid Gland Disorders Treatment Market, By Route of Administration
7.1 Introduction
7.2 Oral
7.3 Injectable
7.4 Topical
7.5 Other Route of Administrations
8 Global Thyroid Gland Disorders Treatment Market, By Drug Type
8.1 Introduction
8.2 Levothyroxine
8.3 Liothyronine
8.4 Propylthiouracil
8.5 Imidazole-Based Compounds
8.6 Other Drug Types
9 Global Thyroid Gland Disorders Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
8.4 Online Pharmacies
8.5 Clinics
8.6 Other Distribution Channels
10 Global Thyroid Gland Disorders Treatment Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Laboratories
12.2 AstraZeneca PLC
12.3 Bristol-Myers Squibb Company
12.4 Eli Lilly and Company
12.5 GlaxoSmithKline PLC
12.6 Merck & Co., Inc.
12.7 Novartis AG
12.8 Pfizer Inc.
12.9 Sanofi S.A.
12.10 Boehringer Ingelheim GmbH
12.11 Amgen Inc.
12.12 Takeda Pharmaceutical Company Limited
12.13 ThyroSafe, LLC
12.14 Hormone Health Network
12.15 Zydus Cadila
12.16 Mylan N.V.
12.17 Hikma Pharmaceuticals PLC
12.18 Endo International PLC
12.19 Genzyme Corporatio
12.20 Roche Holding AG
List of Tables
1 Global Thyroid Gland Disorders Treatment Market Outlook, By Region (2022-2030) ($MN)
2 Global Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2022-2030) ($MN)
3 Global Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2022-2030) ($MN)
4 Global Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2022-2030) ($MN)
5 Global Thyroid Gland Disorders Treatment Market Outlook, By Goiter (2022-2030) ($MN)
6 Global Thyroid Gland Disorders Treatment Market Outlook, By Thyroid Cancer (2022-2030) ($MN)
7 Global Thyroid Gland Disorders Treatment Market Outlook, By Hashimoto's Thyroiditis (2022-2030) ($MN)
8 Global Thyroid Gland Disorders Treatment Market Outlook, By Graves' Disease (2022-2030) ($MN)
9 Global Thyroid Gland Disorders Treatment Market Outlook, By Thyroid Nodules (2022-2030) ($MN)
10 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Type of Disorders (2022-2030) ($MN)
11 Global Thyroid Gland Disorders Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
12 Global Thyroid Gland Disorders Treatment Market Outlook, By Medications (2022-2030) ($MN)
13 Global Thyroid Gland Disorders Treatment Market Outlook, By Hormone Replacement Therapy (2022-2030) ($MN)
14 Global Thyroid Gland Disorders Treatment Market Outlook, By Antithyroid Drugs (2022-2030) ($MN)
15 Global Thyroid Gland Disorders Treatment Market Outlook, By Radioactive Iodine Therapy (2022-2030) ($MN)
16 Global Thyroid Gland Disorders Treatment Market Outlook, By Surgery (2022-2030) ($MN)
17 Global Thyroid Gland Disorders Treatment Market Outlook, By Thyroidectomy (2022-2030) ($MN)
18 Global Thyroid Gland Disorders Treatment Market Outlook, By Lobectomy (2022-2030) ($MN)
19 Global Thyroid Gland Disorders Treatment Market Outlook, By Radiofrequency Ablation (2022-2030) ($MN)
20 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Treatment Types (2022-2030) ($MN)
21 Global Thyroid Gland Disorders Treatment Market Outlook, By Nutritional Supplements (2022-2030) ($MN)
22 Global Thyroid Gland Disorders Treatment Market Outlook, By Herbal Remedies (2022-2030) ($MN)
23 Global Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
24 Global Thyroid Gland Disorders Treatment Market Outlook, By Oral (2022-2030) ($MN)
25 Global Thyroid Gland Disorders Treatment Market Outlook, By Injectable (2022-2030) ($MN)
26 Global Thyroid Gland Disorders Treatment Market Outlook, By Topical (2022-2030) ($MN)
27 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Route of Administrations (2022-2030) ($MN)
28 Global Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2022-2030) ($MN)
29 Global Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2022-2030) ($MN)
30 Global Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2022-2030) ($MN)
31 Global Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2022-2030) ($MN)
32 Global Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2022-2030) ($MN)
33 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2022-2030) ($MN)
34 Global Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2022-2030) ($MN)
35 Global Thyroid Gland Disorders Treatment Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
36 Global Thyroid Gland Disorders Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
37 Global Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
38 Global Thyroid Gland Disorders Treatment Market Outlook, By Clinics (2022-2030) ($MN)
39 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
